Tecelra is the first engineered cell therapy for the treatment of certain patients with advanced synovial sarcoma. One year ...

HOUSTON, Oct. 27, 2025 /PRNewswire/ -- Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today ...

Doc Season 2 Episode 9 is a game changing midseason finale with a satisfying reunion, fallout, and collateral damage. Our ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

Scientists have uncovered how leukemia cells manage to escape one of the most commonly used treatments. Over time, these ...

Doc' gave fans a few surprising twists and turns during the season 2 fall finale — but where does the show go from here after ...

Doc Season 2, episode 7, brought forth a significant storyline featuring some crucial societal elements that people often ...

Recognition of specific antigen through the B-cell receptor (BCR) stimulates the activation of B cells, which ultimately results in the production of high-affinity antibodies and the provision of long ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

Memory T cells are established at both lymphoid and peripheral sites following the clearance of an invading pathogen. However, memory T-cell transfer and parabiosis studies have shown that the ...

The controversial 28-point plan dropped suddenly by the Trump administration to Ukraine as a take-it-or-leave it proposition ...

Google Docs originated from web-based word processor Writely. The app would lay the groundwork for such common features as collaborative text editing. Eventually acquired by Google, it was made ...